Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Imagine the potential to unlock the secrets of how our bodies maintain health and prevent disease by understanding how stem cells perceive and adapt to their environment. This quest has driven researchers from The Hospital for Sick Children (SickKids) and Institut Curie to conduct an extensive
Triple-negative breast cancer (TNBC) is a particularly aggressive form of breast cancer, accounting for 15-20% of all breast cancer cases. Known for its poor prognosis and lack of effective treatment options, TNBC presents a significant challenge in oncology. However, recent advancements in spatial
The challenge of maintaining long-term medication adherence in patients with chronic cardiovascular conditions is a significant concern in healthcare, given the impact on patient outcomes and healthcare costs. Researchers at CU Anschutz Medical Campus have embarked on an ambitious study, published
Heart disease remains a leading cause of mortality worldwide, with heart failure accounting for 13 percent of global deaths. The inability of the human heart to regenerate lost muscle cells after birth has driven the exploration of cell-based therapies. Over the past two decades, significant
The recent research focusing on the safety of anti-seizure medications during pregnancy provides new insights that are crucial for expectant mothers. The study, led by Stanford Medicine and published in JAMA Neurology, evaluates the long-term effects of lamotrigine and levetiracetam on children
